Published 16 days ago

Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes

Summary by Firstpost News

The Danish Medicines Agency has decided how much money will be subsidized going forward for non-insulin type 2 diabetic medications. The majority of diabetic medication types still receive subsidies, however there are certain modifications, and a stricter provision is added to some GLP-1 analogs. The alterations take effect on November 25, 2024

0 Articles

All

Left

Center

Right

Firstpost News

Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes

16 days ago·Mumbai, India

Read Full Article

AOL

Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes

Denmark will start putting patients suffering from type 2 diabetes on cheaper drugs before prescribing so-called GLP-1 drugs such as Novo Nordisk's Ozempic, the Danish Medicines Agency said on Wednesday. In 2023, 50% of new patients suffering from type 2 diabetes began treatment with a reimbursed GLP-1 drug without trying a cheaper alternative first, the Medicines Agency said. Demand for Novo Nordisk's diabetes drug Ozempic has soared as many pe…

16 days ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.